RECORDS ARE PUBLISHED REGULATORY ACTIONS. FIELDS THE ISSUING AUTHORITY DID NOT PUBLISH ARE MARKED AS NOT STATED, NEVER FILLED IN.
Drug Eye AfricaNational Actions, Continental Reach
Register / Egypt / DEA-EG-2023-0002
Egyptian Drug Authority · Egypt
DEA-EG-2023-0002
Tier 1 · Regulator-publishedUnclassifiedPublic warningStatus · active
Issuing authority
Egyptian Drug Authority (EDA)
Authority reference
Periodic report no. (2) For 2023
Date issued
19 Apr 2023
Recorded by us
2026-09-06 19:45:29 UTC
Product
Deltaclav 457mg/5ml powder for oral suspension
INN / active substance
Not stated by the issuing authority
Dosage form
Not stated by the issuing authority
Strength
Not stated by the issuing authority
Manufacturer
Not stated by the issuing authority
Manufacturer country
Not stated by the issuing authority
MAH or importer
Not stated by the issuing authority
Batch numbers
All batchesThe authority recalled every batch of this product, so no list was published.
Expiry dates
Not published with the notice
Action type
Public warning
Classification
Not stated by the issuing authority
Indicative severity
Not assessed by Drug Eye Africa
Defect category
Not stated by the issuing authority
Product type
Not stated by the issuing authority
ATC code
Not stated by the issuing authority
Affected markets
Egypt — no market beyond the issuing country was named on the notice
Cross-border event
Not linked to a cross-border event
Notice text
@egyptiandrugauthority www.edaegypt.gov.eg 15301 تحذر هيئة الدواء المصرية من العبوات المقلدة من المستحضر التالي وجميع التشغيلات الأخرى التي تتفق مع المواصفات المذكورة بالعبوة المقلدة كما هو وارد بالمنشور. حيث يمكن التفرقة ظاهرياً بين العبوات الأصلية والعبوات المقلدة للمستحضر المذكور -وذلك بناءً على ماورد إلينا من الشركة صاحبة المستحضر- كالآتى: منشور غش تجاري Deltaclav 457mg/5ml powder for oral suspension 220820 - 220634 تشغيله رقم الشركة المصنعة : شركة العاشر من رمضان للصناعات الدوائية والمستحضرات التشخيصية )راميدا( الشركة صاحبة المستحضر : شركة الدلتا للصناعات الدوائية )دلتا فارما( ٩١ أبريل٣٢٠٢ @egyptiandrugauthority www.edaegypt.gov.eg 15301 في حال وجود شكوى يرجى الرجوع للصيدلي للتأكد من العبوة او الاتصال على الخط www.edaegypt.gov.egالساخن ١٠٣٥١ او الابلاغ عبر الموقع الإلكتروني للهيئة Deltaclav 457mg/5ml powder for oral suspension 220820 - 220634 -213543تشغيله رقم الشركة المصنعة : شركة العاشر من رمضان للصناعات الدوائية والمستحضرات التشخيصية )راميدا( الشركة صاحبة المستحضر : شركة الدلتا للصناعات الدوائية )دلتا فارما(
Original language: ar
Notice text in English
Trade-counterfeiting circular. The Egyptian Drug Authority warns against counterfeit packs of the following product, and of every other batch matching the specifications given on the counterfeit pack as set out in the circular. Genuine and counterfeit packs can be told apart by sight, on the basis of what the company that owns the product has reported to the Authority.
Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
Status
Active
Superseded by
Not superseded. This is the current version.
Version
1

Provenance

Verification tier 1

Where this record came from, and what is held to show it.

Copy of the source
Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.
Ask us for it and check it against the fingerprint below.
Fingerprint
6ef0da823aa71c7cc926997490508d7351962fbd950be1de565c04165cbbcd03
SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
Copy taken
2026-09-06 20:36:32 UTC
Cite this record
Drug Eye Africa (2023). DEA-EG-2023-0002: Deltaclav 457mg/5ml powder for oral suspension — Public warning, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2023/dea-eg-2023-0002

Version history

No version history recorded for this record.
Corrections appear here and in the site-wide log. Records are superseded, never deleted.

Verification

Tier 1Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.

Indexing

This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.

DEA-EG-2023-0002 — Deltaclav 457mg/5ml powder for oral suspension · Drug Eye Africa